- Home
- PCVX vs KNX Comparison
PCVX vs KNX Comparison
Compare PCVX & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- KNX
- Stock Information
- Founded
- PCVX 2013
- KNX 1989
- Country
- PCVX United States
- KNX United States
- Employees
- PCVX N/A
- KNX N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- KNX Trucking Freight/Courier Services
- Sector
- PCVX Health Care
- KNX Industrials
- Exchange
- PCVX Nasdaq
- KNX Nasdaq
- Market Cap
- PCVX 4.0B
- KNX 6.4B
- IPO Year
- PCVX 2020
- KNX 1994
- Fundamental
- Price
- PCVX $41.05
- KNX $44.29
- Analyst Decision
- PCVX Strong Buy
- KNX Strong Buy
- Analyst Count
- PCVX 8
- KNX 17
- Target Price
- PCVX $114.17
- KNX $53.65
- AVG Volume (30 Days)
- PCVX 1.6M
- KNX 4.6M
- Earning Date
- PCVX 11-04-2025
- KNX 10-22-2025
- Dividend Yield
- PCVX N/A
- KNX 1.61%
- EPS Growth
- PCVX N/A
- KNX 280.63
- EPS
- PCVX N/A
- KNX 0.88
- Revenue
- PCVX N/A
- KNX $7,477,640,000.00
- Revenue This Year
- PCVX N/A
- KNX $2.37
- Revenue Next Year
- PCVX N/A
- KNX $5.58
- P/E Ratio
- PCVX N/A
- KNX $50.80
- Revenue Growth
- PCVX N/A
- KNX N/A
- 52 Week Low
- PCVX $27.66
- KNX $36.69
- 52 Week High
- PCVX $116.00
- KNX $61.51
- Technical
- Relative Strength Index (RSI)
- PCVX 48.47
- KNX 50.34
- Support Level
- PCVX $39.87
- KNX $43.28
- Resistance Level
- PCVX $45.90
- KNX $45.39
- Average True Range (ATR)
- PCVX 1.80
- KNX 1.68
- MACD
- PCVX -0.68
- KNX -0.22
- Stochastic Oscillator
- PCVX 16.93
- KNX 20.95
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About KNX Knight-Swift Transportation Holdings Inc.
Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.